Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
NAD⁺ & NMN
Research brief

Secondary analysis links neuronal H3K27me3 aging targets to NMN-responsive genes, nominating CPT2

A secondary analysis of two public mouse datasets found only limited overlap between neuronal age-associated H3K27me3 targets and NMN-responsive genes in metabolic tissues; CPT2 was nominated as the leading candidate for validation. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The authors performed a secondary integrative analysis of two public datasets: GSE190102 on age-associated neuronal H3K27me3 targets and GSE85718, a long-term NMN transcriptomic dataset from mouse skeletal muscle, liver and white adipose tissue. [1]

  2. The analysis found 23 genes shared between 21,155 aging H3K27me3-associated targets and 35 robust NMN-rescue genes, but gene-level overlap was not statistically persuasive and pathway-level convergence was absent. [1]

  3. CPT2 was nominated as the leading candidate, showing age-associated H3K27me3 gain, NMN-induced expression increase in old animals and membership in the mitochondrial fatty-acid oxidation pathway; the findings do not support a broad reversal of neuronal epigenetic aging by NMN. [1]

The source at a glance

Study type / format
Secondary integrative analysis of two public datasets (abstract)
Population / context
Mice; neuronal H3K27me3 targets and skeletal muscle, liver and white adipose tissue transcriptomes from public datasets
Summary based on
Study abstract
Original publication
July 18, 2026

Two public mouse datasets combined

The authors performed a secondary integrative analysis of two public datasets. GSE190102 covered age-associated neuronal H3K27me3 targets mapped through a region-gene framework. GSE85718 was a long-term NMN transcriptomic dataset from skeletal muscle, liver and white adipose tissue in mice. The stated objectives were to quantify overlap between neuronal age-associated H3K27me3 targets and robust NMN-responsive genes in peripheral metabolic tissues, classify shared genes by directional concordance under repressive chromatin logic, and identify high-priority mechanistic candidates.

Supporting source [1]

Limited overlap; CPT2 nominated as candidate

The analysis identified 23 genes shared between 21,155 aging H3K27me3-associated targets and 35 robust NMN-rescue genes. Because the aging target set was extremely broad, the gene-level overlap was not statistically persuasive, and pathway-level convergence was absent. Under repressive-mark direction logic, 14 of the 23 shared genes were concordant, meaning the NMN expression effect opposed the expected consequence of age-associated H3K27me3 remodeling. CPT2 emerged as the leading candidate: it showed age-associated H3K27me3 gain (log-fold change +3.504), NMN-induced expression increase in old animals (interaction coefficient +0.201) and membership in the mitochondrial fatty-acid oxidation pathway. Within the downstream shared-gene mitochondrial analysis, CPT2 was the only mitochondrial-core gene, with nominal enrichment only.

Supporting source [1]

No broad reversal shown; validation still needed

The authors state that these findings do not support a broad reversal of neuronal epigenetic aging by NMN. Instead, they identify CPT2 as a biologically coherent and experimentally tractable candidate linking age-related repressive chromatin remodeling to NMN-responsive mitochondrial metabolism. This is a secondary analysis of existing public datasets, not a new experiment; CPT2 is nominated for targeted validation, and the abstract reports no such validation.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. This is a secondary analysis of two public datasets, not a new experiment. The aging target set was extremely broad, gene-level overlap was not statistically persuasive, pathway-level convergence was absent, and CPT2 enrichment was nominal only. CPT2 is nominated for targeted validation, which the abstract does not report. Findings are in mice and do not establish human lifespan or health benefits.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    secondary integrative analysis of two public datasets
  2. Finding 2 ↑

    gene-level overlap was not statistically persuasive
  3. Finding 3 ↑

    CPT2 emerged as the leading candidate

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…